[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019, 69:7-34.
[2] 齐金蕾,王黎君,周脉耕,等.1990-2013年中国男性前列腺癌疾病负担分析[J].中华流行病学杂志, 2016, 37:778-782.
[3] Borghesi M, Ahmed H, Nam R, et al. Complications after systematic, random, and image-guided prostate biopsy[J]. Eur Urol, 2017, 71:353-365.
[4] Turner B, Aslet Ph, Drudge-Coates L, et al. Transrectal ultrasound guided biopsy of the prostate [M]// European Association of Urology Nurses, Evidence-based Guidelines for Best Practice in Health Care. The Netherlands: Drukkerij Gelderland, 2011:22-23.
[5] Tillier C, Cornford P, De Lauw G, et al. Transrectal ultrasound guided biopsy of the prostate [M]// European Association of Urology Nurses, Evidence-based Guidelines for Best Practice in Urological Health Care. The Netherlands: Gld Print & Media, 2019:28-31.
[6] Maan Z, Cutting CW, Patel U, et al. Morbidity of transrectal ultrasonography-guided prostate biopsies in patients after the continued use of low-dose aspirin[J]. BJU Int, 2003, 91:798-800.
[7] Ihezue CU, Smart J, Dewbury KC, et al. Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications[J]. Clin Radiol, 2005, 60:459-463.
[8] Giannarini G, Mogorovich A, Valent F, et al. Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial[J]. Urology, 2007, 70:501-505.
[9] Kariotis I, Philippou P, Volanis D, et al. Safety of ultrasound-guided transrectal extended prostate biopsy in patients receiving low-dose aspirin[J]. Int Braz J Urol, 2010, 36:308-316.
[10] Vasudeva P, Kumar N, Kumar A, et al. Safety of 12 core transrectal ultrasound guided prostate biopsy in patients on aspirin[J]. Int Braz J Urol, 2015, 41:1096-1100.
[11] Halliwell OT, Yadegafar G, Lane C, et al. Transrectal ultrasound-guided biopsy of the prostate: aspirin increases the incidence of minor bleeding complications[J]. Clin Radiol, 2008, 63:557-561.
[12] Chowdhury R, Abbas A, Idriz S, et al. Should warfarin or aspirin be stopped prior to prostate biopsy? An analysis of bleeding complications related to increasing sample number regimes[J]. Clin Radiol, 2012, 67:64-70.
[13] Tanabe K, Hattori T, Kobayashi H, et al. Is it safe to continue antithrombotic agents before prostate biopsy?[J]. Prostate Int, 2019, 7:78-81.
[14] Ozveren B, Türkeri L. Massive rectal bleeding after prostate biopsy controlled by endoclipping in a patient using acetylsalicylic acid[J]. Can Urol Assoc J, 2013, 7:442-444.
[15] Guo LQ, So BC, Sadler D, et al. Intraprostatic hematoma with active bleeding post-prostate biopsy[J]. Can Urol Assoc J, 2014, 8:888-890.
[16] Asano T, Kobayashi S, Yano M, et al. Continued administration of antithrombotic agents during transperineal prostate biopsy[J]. Int Braz J Urol, 2015, 41:116-123.
[17] Saito K, Washino S, Nakamura Y, et al. Transperineal ultrasound-guided prostate biopsy is safe even when patients are on combination antiplatelet and/or anticoagulation therapy[J]. BMC Urol, 2017, 17:53-58.
[18] Mai Z, Yan W, Zhou Y, et al. Transperineal template-guided prostate biopsy: 10 years of experience[J]. BJU Int, 2016, 117:424-429.
[19] Sundström J, Hedberg J, Thuresson M, et al. Low-dose aspirin discontinuation and risk of cardiovascular events: a swedish nationwide, population-based cohort study[J]. Circulation, 2017, 136:1183-1192.
[20] García Rodríguez LA, Cea Soriano L, Hill C, et al. Increased risk of stroke after discontinuation of acetyl-salicylic acid: a UK primary care study[J]. Neurology, 2011, 76:740-746. |
